BusinessHemispherx Biopharma to Present at the 9th Annual LD Micro Main EventBy Nasdaq OMXNov 21, 2016, 1:30 PM UTC
BusinessETST Announces 60-Patient Clinical Prelaunch Study for its MSN-2 Medical Device for the Diagnosis of Chlamydia & Gonorrhea, ETST Elects Dr. Michel Aubé as New CEO & CSO, and Nickolas Tabraue as President.By Nasdaq OMXNov 21, 2016, 1:15 PM UTC
BusinessInnocoll to Report Third Quarter 2016 Financial Results and Host Webcast and Conference Call on November 22, 2016By Nasdaq OMXNov 15, 2016, 1:30 PM UTC
BusinessHemispherx Biopharma Announces Financial Results in its Quarterly Report for the Nine Months Ended September 30, 2016By Nasdaq OMXNov 14, 2016, 9:36 PM UTC
BusinessInnocoll Holdings plc to Present at the Stifel 2016 Healthcare ConferenceBy Nasdaq OMXNov 14, 2016, 1:30 PM UTC
BusinessHemispherx Biopharma Featured in Corporate America News Magazine Special Report “Capturing the Power of Immune Response to Treat Disease: Biotech Bounce Back”By Nasdaq OMXNov 8, 2016, 1:30 PM UTC
BusinessFate Therapeutics Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 7, 2016, 9:01 PM UTC
BusinessFate Therapeutics Announces Oral Presentation on Natural Killer Cell Product Candidate FATE-NK100 at the 2016 ASH Annual MeetingBy Nasdaq OMXNov 3, 2016, 8:59 PM UTC
